InvestorsHub Logo
Followers 0
Posts 94
Boards Moderated 0
Alias Born 05/10/2012

Re: gfp927z post# 289

Thursday, 05/24/2012 4:48:55 PM

Thursday, May 24, 2012 4:48:55 PM

Post# of 689
I have to wonder at the similarity between Poly's pipeline and IBM's.

"They try to mimic what the immune system does: the polymer attaches to the bacteria’s membrane and then facilitates destabilization of the membrane. It falls apart, everything falls out and there’s little opportunity for it to develop resistance to these polymers."

That sounds eerily similar to the mechanism of action of all of Poly's compounds, both in-trial and in pre-clinical status. I have to wonder how similar the two technologies are? Does Poly have some basis for a patent infringement lawsuit?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.